Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Million-Person african study aims to fill health data gap

NCT ID NCT07427355

Knowledge-focused Sponsor: Alliance For Medical Research in Africa Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is gathering health information from one million people across Africa to better understand noncommunicable diseases like heart disease, cancer, and diabetes. Researchers are looking at risk factors such as weight, blood pressure, and smoking. The goal is to produce reliable data that can guide health policies in Africa.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could provide crucial data to help African countries better prevent and manage diseases like heart disease and cancer.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly improve health. Results depend on data quality and may take years to influence policy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,000,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2025

Expected to finish

Jun 2030

An estimate. End dates often move.

Lead sponsor

A research network

The lead sponsor is a research network or cooperative group.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The ASANDE platform integrates harmonised individual-level data from more than 1 million participants across over 100 countries and six continents, derived from nationally representative cross-sectional surveys and population-based longitudinal cohort studies. Participating studies are organised into major geographical region: Asia; Eastern Europe; North Africa and the Middle East; North and Latin America; Sub-Saharan Africa; and Western Europe, thereby facilitating rigorous regional and inter-regional comparisons. The harmonised dataset provides standardised and comparable information on major noncommunicable disease (NCD) risk factors, including body-mass index, systolic blood pressure, non-high-density lipoprotein cholesterol, current smoking status, and diabetes mellitus, together with data on major NCD outcomes, including cardiovascular diseases, cancer, chronic respiratory diseases, and cause-specific mortality.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

\- Inclusion criteria We included cross-sectional surveys and longitudinal population-based studies providing individual-level data on established noncommunicable disease (NCD) risk factors, including body-mass index, systolic blood pressure, non-high-density lipoprotein cholesterol, current smoking status, and diabetes mellitus, together with information on predefined NCD outcomes of interest (including cardiovascular diseases, cancer, chronic respiratory diseases, and other major NCDs). For longitudinal studies, prospective ascertainment of incident events and mortality was required. \- Exclusion criteria Participants were excluded if they were younger than 18 years at the time of assessment, had missing data on the outcome of interest, had no available information on the exposure variables (NCD risk factors), or, for longitudinal analyses, had a documented history of the respective NCD outcome at baseline.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cancer cardiovascular disorder neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cancer Cardio vascular disease Cardiovascular Mortality

Contacts and locations

Locations

  • Institut Pasteur de Dakar; Address: 36, Avenue Pasteur, B.P. 220 - Dakar, Senegal

    Dakar, Senegal

More trials for these conditions

Other studies related to the condition(s) this trial covers.